相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer's disease
Zhentao Zhang et al.
NATURE COMMUNICATIONS (2015)
Alzheimer disease and amyotrophic lateral sclerosis: an etiopathogenic connection
Xiaochuan Wang et al.
ACTA NEUROPATHOLOGICA (2014)
P3 SAR exploration of biphenyl carbamate based Legumain inhibitors
Catherine Higgins et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Cytoplasmic SET induces tau hyperphosphorylation through a decrease of methylated phosphatase 2A
Stephanie Chasseigneaux et al.
BMC NEUROSCIENCE (2014)
Asparagine endopeptidase cleaves tau and promotes neurodegeneration
Hanna Rosenmann
NATURE MEDICINE (2014)
Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease
Zhentao Zhang et al.
NATURE MEDICINE (2014)
The Asparaginyl Endopeptidase Legumain Is Essential for Functional Recovery after Spinal Cord Injury in Adult Zebrafish
Liping Ma et al.
PLOS ONE (2014)
Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLDALS spectrum disorders
Jonathan Janssens et al.
HUMAN MOLECULAR GENETICS (2013)
Activation of Asparaginyl Endopeptidase Leads to Tau Hyperphosphorylation in Alzheimer Disease
Gustavo Basurto-Islas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis
Shuo-Chien Ling et al.
NEURON (2013)
Synthesis and evaluation of aza-peptidyl inhibitors of the lysosomal asparaginyl endopeptidase, legumain
Jiyoun Lee et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Drug transport across the blood-brain barrier
William M. Pardridge
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
Asparaginyl endopeptidase cleaves TDP-43 in brain
Jeremy H. Herskowitz et al.
PROTEOMICS (2012)
Asparagine Endopeptidase Controls Anti-Influenza Virus Immune Responses through TLR7 Activation
Sophia Maschalidi et al.
PLOS PATHOGENS (2012)
Asparagine endopeptidase is required for normal kidney physiology and homeostasis
Gail Miller et al.
FASEB JOURNAL (2011)
Mechanism of inhibition of PP2A activity and abnormal hyperphosphorylation of tau by I2PP2A/SET
Lisette Arnaud et al.
FEBS LETTERS (2011)
Development of Near-Infrared Fluorophore (NIRF)-Labeled Activity-Based Probes for in Vivo Imaging of Legumain
Jiyoun Lee et al.
ACS CHEMICAL BIOLOGY (2010)
The carboxy-terminal fragment of inhibitor-2 of protein phosphatase-2A induces Alzheimer disease pathology and cognitive impairment
Xiaochuan Wang et al.
FASEB JOURNAL (2010)
TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration
Clotilde Lagier-Tourenne et al.
HUMAN MOLECULAR GENETICS (2010)
Hypothesis on the Relationship Between the Change in Intracellular pH and Incidence of Sporadic Alzheimer's Disease or Vascular Dementia
Boyan Fang et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2010)
The asparaginyl endopeptidase legumain after experimental stroke
Taku Ishizaki et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2010)
Critical Role for Asparagine Endopeptidase in Endocytic Toll-like Receptor Signaling in Dendritic Cells
Fernando E. Sepulveda et al.
IMMUNITY (2009)
Reduced Levels of Amyloid-beta-Binding Proteins in Cerebrospinal Fluid from Alzheimer's Disease Patients
Sara F. Hansson et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological Features of TDP-43 Proteinopathies
Lionel M. Igaz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Mice lacking asparaginyl endopeptidase develop disorders resembling hemophagocytic syndrome
Chi-Bun Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Lionel M. Igaz et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Expression of the cysteine protease legumain in vascular lesions and functional implications in atherogenesis
Valerie Clerin et al.
ATHEROSCLEROSIS (2008)
Aza-peptidyl Michael acceptors.: A new class of potent and selective inhibitors of asparaginyl endopeptidases (legumains) from evolutionarily diverse pathogens
Marion G. Gotz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Neuroprotective actions of PIKE-L by inhibition of SET proteolytic degradation by asparagine endopeptidase
Zhixue Liu et al.
MOLECULAR CELL (2008)
Legumain/asparaginyl endopeptidase controls extracellular matrix remodeling through the degradation of fibronectin in mouse renal proximal tubular cells
Yoshikata Morita et al.
FEBS LETTERS (2007)
A novel panel of cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer's disease versus normal aging and frontotemporal dementia
A. H. Simonsen et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Tetsuaki Arai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Involvement of I2PP2A in the abnormal hyperphosphorylation of tau and its reversal by Memantine
Muhammad Omar Chohan et al.
FEBS LETTERS (2006)
Comprehensive regional and temporal gene expression profiling of the rat brain during the first 24 h after experimental stroke identifies dynamic ischemia-induced gene expression patterns, and reveals a biphasic activation of genes in surviving tissue
M Rickhag et al.
JOURNAL OF NEUROCHEMISTRY (2006)
PIKE/nuclear PI 3-kinase signaling in preventing programmed cell death
KQ Ye
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice
R Maehr et al.
JOURNAL OF IMMUNOLOGY (2005)
Asparagine deamidation perturbs antigen presentation on class II major histocompatibility complex molecules
CX Moss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Legumain expression in relation to clinicopathologic and biological variables in colorectal cancer
RV Murthy et al.
CLINICAL CANCER RESEARCH (2005)
PIKE GTPase: a novel mediator of phosphoinositide signaling
KQ Ye et al.
JOURNAL OF CELL SCIENCE (2004)
An animal model of hemophagocytic lymphohistiocytosis (HLH):: CD8+ T cells and interferon gamma are essential for the disorder
MB Jordan et al.
BLOOD (2004)
Multistep autoactivation of asparaginyl endopeptidase in vitro and in vivo
DTN Ni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Alzheimer's missing link?
[Anonymous]
MOLECULAR THERAPY (2003)
Biosynthetic processing of cathepsins and lysosomal degradation are abolished in asparaginyl endopeptidase-deficient mice
K Shirahama-Noda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease
TC Gamblin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Triple-transgenic model of Alzheimer's disease with plaques and tangles:: Intracellular Aβ and synaptic dysfunction
S Oddo et al.
NEURON (2003)
Prothymosin α is processed to thymosin α1 and thymosin α11 by a lysosomal asparaginyl endopeptidase
CS Sarandeses et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Asparagine endopeptidase can initiate the removal of the MHC class II invariant chain chaperone
B Manoury et al.
IMMUNITY (2003)
Inhibition of mammalian legumain by Michael acceptors and AzaAsn-halomethylketones
AJ Niestroj et al.
BIOLOGICAL CHEMISTRY (2002)
Apolipoprotein E4 potentiates amyloid β peptide-induced lysosomal leakage and apoptosis in neuronal cells
ZS Ji et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP
B Manoury et al.
NATURE IMMUNOLOGY (2002)
Lysosomal membrane damage in soluble Aβ-mediated cell death in Alzheimer's disease
K Ditaranto et al.
NEUROBIOLOGY OF DISEASE (2001)
分享论文
